XML 47 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 23, 2012
Sep. 25, 2011
Cash flows from operating activities:    
Net income (loss) $ 151,692 $ (410,627)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:    
Depreciation and amortization 108,411 156,706
Foreign currency transaction loss (gain) (5,620) 9,594
Accretion of bond discount 342 339
Impairment expense 1,342 11,640
Loss on property disposals 5,134 177
Share-based compensation 465 418
Deferred income tax benefit 0 (10,707)
Changes in operating assets and liabilities:    
Restricted cash and cash equivalents 8,153 3,645
Trade accounts and other receivables (3,172) (42,871)
Inventories (94,972) 101,565
Prepaid expenses and other current assets (1,120) 34,824
Accounts payable, accrued expenses and other current liabilities 9,636 18,625
Income taxes (14,428) 1,030
Deposits 734 2,180
Long-term pension and other postretirement obligations (7,120) (3,848)
Other operating assets and liabilities (3,516) (2,170)
Cash provided by (used in) operating activities 155,961 (129,480)
Cash flows from investing activities:    
Acquisitions of property, plant and equipment (62,110) (121,869)
Purchases of investment securities (162) (4,536)
Proceeds from sale or maturity of investment securities 688 14,631
Proceeds from property disposals 28,687 7,502
Cash used in investing activities (32,897) (104,272)
Cash flows from financing activities:    
Proceeds from revolving line of credit and long-term borrowings 595,800 804,689
Payments on revolving line of credit, long-term borrowings and capital lease obligations (853,008) (669,832)
Proceeds from note payable to JBS USA Holdings, Inc. 0 50,000
Payment of note payable to JBS USA Holdings, Inc. (50,000) 0
Proceeds from sale of common stock, net 198,282 0
Purchase of remaining interest in subsidiary 0 (2,504)
Payment of capitalized loan costs 0 (4,395)
Other financing activities 0 (106)
Cash provided by (used in) financing activities (108,926) 177,852
Effect of exchange rate changes on cash and cash equivalents (717) (3,273)
Increase (decrease) in cash and cash equivalents 13,421 (59,173)
Cash and cash equivalents, beginning of period 41,609 106,077
Cash and cash equivalents, end of period $ 55,030 $ 46,904